BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ohya S, Kajikuri J, Endo K, Kito H, Matsui M. KCa1.1 K+ Channel Inhibition Overcomes Resistance to Antiandrogens and Doxorubicin in a Human Prostate Cancer LNCaP Spheroid Model. Int J Mol Sci 2021;22:13553. [PMID: 34948357 DOI: 10.3390/ijms222413553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hashemi M, Ghadyani F, Hasani S, Olyaee Y, Raei B, Khodadadi M, Ziyarani MF, Basti FA, Tavakolpournegari A, Matinahmadi A, Salimimoghadam S, Aref AR, Taheriazam A, Entezari M, Ertas YN. Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104112] [Reference Citation Analysis]
2 Zhao J, Li M, Xu J, Cheng W. The modulation of ion channels in cancer chemo-resistance. Front Oncol 2022;12:945896. [DOI: 10.3389/fonc.2022.945896] [Reference Citation Analysis]